UniProt ID | DCP1A_HUMAN | |
---|---|---|
UniProt AC | Q9NPI6 | |
Protein Name | mRNA-decapping enzyme 1A | |
Gene Name | DCP1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 582 | |
Subcellular Localization | Cytoplasm, P-body . Nucleus . Co-localizes with NANOS3 in the processing bodies (By similarity). Predominantly cytoplasmic, in processing bodies (PB) (PubMed:16364915). Nuclear, after TGFB1 treatment. Translocation to the nucleus depends on interacti | |
Protein Description | Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. Contributes to the transactivation of target genes after stimulation by TGFB1.. | |
Protein Sequence | MEALSRAGQEMSLAALKQHDPYITSIADLTGQVALYTFCPKANQWEKTDIEGTLFVYRRSASPYHGFTIVNRLNMHNLVEPVNKDLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHRIAKLMADVVEEETRRSQQAARDKQSPSQANGCSDHRPIDILEMLSRAKDEYERNQMGDSNISSPGLQPSTQLSNLGSTETLEEMPSGSQDKSAPSGHKHLTVEELFGTSLPKEQPAVVGLDSEEMERLPGDASQKEPNSFLPFPFEQLGGAPQSETLGVPSAAHHSVQPEITTPVLITPASITQSNEKHAPTYTIPLSPVLSPTLPAEAPTAQVPPSLPRNSTMMQAVKTTPRQRSPLLNQPVPELSHASLIANQSPFRAPLNVTNTAGTSLPSVDLLQKLRLTPQHDQIQTQPLGKGAMVASFSPAAGQLATPESFIEPPSKTAAARVAASASLSNMVLAPLQSMQQNQDPEVFVQPKVLSSAIQVAGAPLVTATTTAVSSVLLAPSVFQQTVTRSSDLERKASSPSPLTIGTPESQRKPSIILSKSQLQDTLIHLIKNDSSFLSTLHEVYLQVLTKNKDNHNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MEALSRAGQEMS ---CHHHHHHHHHHH | 27.42 | 20068231 | |
12 | Phosphorylation | SRAGQEMSLAALKQH HHHHHHHHHHHHHHC | 17.69 | 20068231 | |
22 | Phosphorylation | ALKQHDPYITSIADL HHHHCCCCHHHHHHH | 23.92 | 20068231 | |
47 | Ubiquitination | PKANQWEKTDIEGTL CCCCCCEEECCCCEE | 48.84 | 22053931 | |
48 | Ubiquitination | KANQWEKTDIEGTLF CCCCCEEECCCCEEE | 30.60 | 29967540 | |
60 | Phosphorylation | TLFVYRRSASPYHGF EEEEEEECCCCCCCE | 24.89 | 28787133 | |
62 | Phosphorylation | FVYRRSASPYHGFTI EEEEECCCCCCCEEE | 27.51 | 23401153 | |
64 | Phosphorylation | YRRSASPYHGFTIVN EEECCCCCCCEEEEE | 16.45 | 28122231 | |
68 | Phosphorylation | ASPYHGFTIVNRLNM CCCCCCEEEEECCCC | 28.71 | 23403867 | |
70 | Ubiquitination | PYHGFTIVNRLNMHN CCCCEEEEECCCCCC | 2.87 | 29967540 | |
94 | Ubiquitination | EFQLHEPFLLYRNAS HHEECCCEEHHCCCC | 7.18 | 29967540 | |
108 | Ubiquitination | SLSIYSIWFYDKNDC CEEEEEEEEECCCHH | 4.64 | 29967540 | |
120 | Acetylation | NDCHRIAKLMADVVE CHHHHHHHHHHHHHH | 36.10 | 25953088 | |
120 | Ubiquitination | NDCHRIAKLMADVVE CHHHHHHHHHHHHHH | 36.10 | 29967540 | |
130 | Phosphorylation | ADVVEEETRRSQQAA HHHHHHHHHHHHHHH | 34.36 | 26074081 | |
133 | Phosphorylation | VEEETRRSQQAARDK HHHHHHHHHHHHHHC | 24.29 | 26074081 | |
140 | Ubiquitination | SQQAARDKQSPSQAN HHHHHHHCCCHHHCC | 47.31 | - | |
142 | Phosphorylation | QAARDKQSPSQANGC HHHHHCCCHHHCCCC | 32.05 | 26846344 | |
143 | Ubiquitination | AARDKQSPSQANGCS HHHHCCCHHHCCCCC | 28.15 | 29967540 | |
144 | Phosphorylation | ARDKQSPSQANGCSD HHHCCCHHHCCCCCC | 47.36 | 26846344 | |
150 | Phosphorylation | PSQANGCSDHRPIDI HHHCCCCCCCCCHHH | 37.54 | 26846344 | |
156 | Phosphorylation | CSDHRPIDILEMLSR CCCCCCHHHHHHHHH | 41.94 | 32142685 | |
157 | Ubiquitination | SDHRPIDILEMLSRA CCCCCHHHHHHHHHC | 3.48 | 29967540 | |
160 | Phosphorylation | RPIDILEMLSRAKDE CCHHHHHHHHHCHHH | 3.55 | 32142685 | |
162 | Phosphorylation | IDILEMLSRAKDEYE HHHHHHHHHCHHHHH | 28.96 | 23927012 | |
168 | Phosphorylation | LSRAKDEYERNQMGD HHHCHHHHHHHCCCC | 30.26 | 28796482 | |
168 (in isoform 2) | Phosphorylation | - | 30.26 | 20068231 | |
171 (in isoform 2) | Phosphorylation | - | 25.01 | 20068231 | |
174 (in isoform 2) | Phosphorylation | - | 25.98 | 20068231 | |
176 | Phosphorylation | ERNQMGDSNISSPGL HHHCCCCCCCCCCCC | 30.27 | 21712546 | |
179 | Phosphorylation | QMGDSNISSPGLQPS CCCCCCCCCCCCCCC | 34.43 | 30278072 | |
180 | Phosphorylation | MGDSNISSPGLQPST CCCCCCCCCCCCCCH | 21.13 | 30278072 | |
186 | Phosphorylation | SSPGLQPSTQLSNLG CCCCCCCCHHHHCCC | 18.80 | 21955146 | |
187 | Phosphorylation | SPGLQPSTQLSNLGS CCCCCCCHHHHCCCC | 39.97 | 21955146 | |
187 | Ubiquitination | SPGLQPSTQLSNLGS CCCCCCCHHHHCCCC | 39.97 | 24816145 | |
190 | Phosphorylation | LQPSTQLSNLGSTET CCCCHHHHCCCCCCC | 21.86 | 30278072 | |
191 | Ubiquitination | QPSTQLSNLGSTETL CCCHHHHCCCCCCCH | 57.95 | 29967540 | |
194 | Phosphorylation | TQLSNLGSTETLEEM HHHHCCCCCCCHHHC | 26.66 | 25022875 | |
195 | Phosphorylation | QLSNLGSTETLEEMP HHHCCCCCCCHHHCC | 31.06 | 21712546 | |
197 | Phosphorylation | SNLGSTETLEEMPSG HCCCCCCCHHHCCCC | 39.29 | 25022875 | |
198 | Phosphorylation | NLGSTETLEEMPSGS CCCCCCCHHHCCCCC | 4.23 | 32142685 | |
203 | Phosphorylation | ETLEEMPSGSQDKSA CCHHHCCCCCCCCCC | 50.17 | 20873877 | |
205 | Phosphorylation | LEEMPSGSQDKSAPS HHHCCCCCCCCCCCC | 39.27 | 20873877 | |
215 | Ubiquitination | KSAPSGHKHLTVEEL CCCCCCCCCEEHHHH | 43.78 | 29967540 | |
218 | Phosphorylation | PSGHKHLTVEELFGT CCCCCCEEHHHHHCC | 26.12 | 28060719 | |
225 | Phosphorylation | TVEELFGTSLPKEQP EHHHHHCCCCCCCCC | 21.54 | 29255136 | |
225 | Ubiquitination | TVEELFGTSLPKEQP EHHHHHCCCCCCCCC | 21.54 | 24816145 | |
226 | Phosphorylation | VEELFGTSLPKEQPA HHHHHCCCCCCCCCC | 42.95 | 29255136 | |
229 | Ubiquitination | LFGTSLPKEQPAVVG HHCCCCCCCCCCEEC | 74.42 | 29967540 | |
238 | Ubiquitination | QPAVVGLDSEEMERL CCCEECCCHHHHHCC | 48.34 | 29967540 | |
239 | O-linked_Glycosylation | PAVVGLDSEEMERLP CCEECCCHHHHHCCC | 40.26 | 23301498 | |
242 | Phosphorylation | VGLDSEEMERLPGDA ECCCHHHHHCCCCCC | 2.97 | 32142685 | |
243 | Phosphorylation | GLDSEEMERLPGDAS CCCHHHHHCCCCCCC | 55.11 | 32142685 | |
247 | Phosphorylation | EEMERLPGDASQKEP HHHHCCCCCCCCCCC | 47.94 | 32142685 | |
274 | Ubiquitination | GAPQSETLGVPSAAH CCCCHHCCCCCCHHC | 5.97 | 24816145 | |
276 | Ubiquitination | PQSETLGVPSAAHHS CCHHCCCCCCHHCCC | 3.68 | 29967540 | |
277 | Phosphorylation | QSETLGVPSAAHHSV CHHCCCCCCHHCCCC | 19.22 | 32142685 | |
280 | Phosphorylation | TLGVPSAAHHSVQPE CCCCCCHHCCCCCCC | 12.79 | 32142685 | |
281 | Phosphorylation | LGVPSAAHHSVQPEI CCCCCHHCCCCCCCC | 17.30 | 32142685 | |
289 | Phosphorylation | HSVQPEITTPVLITP CCCCCCCCCCEEECC | 24.32 | 26074081 | |
290 | Phosphorylation | SVQPEITTPVLITPA CCCCCCCCCEEECCC | 19.63 | 26074081 | |
295 | Phosphorylation | ITTPVLITPASITQS CCCCEEECCCCCCCC | 14.51 | - | |
308 | Ubiquitination | QSNEKHAPTYTIPLS CCCCCCCCEEEEECC | 26.17 | 24816145 | |
309 | Phosphorylation | SNEKHAPTYTIPLSP CCCCCCCEEEEECCC | 33.80 | 29255136 | |
310 | Phosphorylation | NEKHAPTYTIPLSPV CCCCCCEEEEECCCC | 11.12 | 30278072 | |
311 | Phosphorylation | EKHAPTYTIPLSPVL CCCCCEEEEECCCCC | 20.71 | 29255136 | |
315 | Phosphorylation | PTYTIPLSPVLSPTL CEEEEECCCCCCCCC | 13.96 | 29255136 | |
319 | Phosphorylation | IPLSPVLSPTLPAEA EECCCCCCCCCCCCC | 18.97 | 29255136 | |
321 | Phosphorylation | LSPVLSPTLPAEAPT CCCCCCCCCCCCCCC | 41.83 | 29255136 | |
325 | Ubiquitination | LSPTLPAEAPTAQVP CCCCCCCCCCCCCCC | 53.92 | 29967540 | |
328 | Phosphorylation | TLPAEAPTAQVPPSL CCCCCCCCCCCCCCC | 36.45 | 29255136 | |
329 | Phosphorylation | LPAEAPTAQVPPSLP CCCCCCCCCCCCCCC | 13.81 | 32142685 | |
334 | Phosphorylation | PTAQVPPSLPRNSTM CCCCCCCCCCCCCHH | 44.96 | 23927012 | |
339 | Phosphorylation | PPSLPRNSTMMQAVK CCCCCCCCHHHHHHH | 20.96 | 26074081 | |
340 | Phosphorylation | PSLPRNSTMMQAVKT CCCCCCCHHHHHHHC | 21.88 | 26074081 | |
346 | Acetylation | STMMQAVKTTPRQRS CHHHHHHHCCHHHCC | 50.09 | 25953088 | |
346 | Ubiquitination | STMMQAVKTTPRQRS CHHHHHHHCCHHHCC | 50.09 | 24816145 | |
347 | Phosphorylation | TMMQAVKTTPRQRSP HHHHHHHCCHHHCCC | 35.12 | 28450419 | |
348 | Phosphorylation | MMQAVKTTPRQRSPL HHHHHHCCHHHCCCC | 15.68 | 27422710 | |
353 | Phosphorylation | KTTPRQRSPLLNQPV HCCHHHCCCCCCCCC | 16.15 | 29255136 | |
359 | Ubiquitination | RSPLLNQPVPELSHA CCCCCCCCCCCCCHH | 42.42 | 29967540 | |
361 | Ubiquitination | PLLNQPVPELSHASL CCCCCCCCCCCHHHH | 43.42 | 29967540 | |
363 | Phosphorylation | LNQPVPELSHASLIA CCCCCCCCCHHHHHC | 3.58 | 32142685 | |
364 | Phosphorylation | NQPVPELSHASLIAN CCCCCCCCHHHHHCC | 18.49 | 23927012 | |
366 | Phosphorylation | PVPELSHASLIANQS CCCCCCHHHHHCCCC | 11.58 | 32142685 | |
367 | Phosphorylation | VPELSHASLIANQSP CCCCCHHHHHCCCCC | 18.19 | 23927012 | |
369 | Phosphorylation | ELSHASLIANQSPFR CCCHHHHHCCCCCCC | 2.91 | 32142685 | |
373 | Phosphorylation | ASLIANQSPFRAPLN HHHHCCCCCCCCCCE | 26.30 | 25159151 | |
376 | Asymmetric dimethylarginine | IANQSPFRAPLNVTN HCCCCCCCCCCEEEC | 38.38 | - | |
376 | Methylation | IANQSPFRAPLNVTN HCCCCCCCCCCEEEC | 38.38 | 24129315 | |
378 | Ubiquitination | NQSPFRAPLNVTNTA CCCCCCCCCEEECCC | 21.88 | 29967540 | |
382 | Phosphorylation | FRAPLNVTNTAGTSL CCCCCEEECCCCCCC | 26.27 | 20068231 | |
384 | Phosphorylation | APLNVTNTAGTSLPS CCCEEECCCCCCCCC | 19.66 | 20068231 | |
387 | Phosphorylation | NVTNTAGTSLPSVDL EEECCCCCCCCCHHH | 25.32 | 28348404 | |
388 | O-linked_Glycosylation | VTNTAGTSLPSVDLL EECCCCCCCCCHHHH | 37.05 | 23301498 | |
388 | Phosphorylation | VTNTAGTSLPSVDLL EECCCCCCCCCHHHH | 37.05 | 28348404 | |
391 | Phosphorylation | TAGTSLPSVDLLQKL CCCCCCCCHHHHHHH | 33.29 | 20068231 | |
397 | Ubiquitination | PSVDLLQKLRLTPQH CCHHHHHHHCCCCCC | 35.23 | 29967540 | |
399 | Ubiquitination | VDLLQKLRLTPQHDQ HHHHHHHCCCCCCCC | 43.48 | 29967540 | |
401 | Phosphorylation | LLQKLRLTPQHDQIQ HHHHHCCCCCCCCCC | 17.92 | 29255136 | |
402 | Phosphorylation | LQKLRLTPQHDQIQT HHHHCCCCCCCCCCC | 33.82 | 32142685 | |
404 | Phosphorylation | KLRLTPQHDQIQTQP HHCCCCCCCCCCCCC | 30.10 | 32142685 | |
407 | Phosphorylation | LTPQHDQIQTQPLGK CCCCCCCCCCCCCCC | 6.27 | 32142685 | |
409 | Phosphorylation | PQHDQIQTQPLGKGA CCCCCCCCCCCCCCC | 33.51 | 23927012 | |
416 | Ubiquitination | TQPLGKGAMVASFSP CCCCCCCCEEEEECC | 7.86 | 29967540 | |
420 | Phosphorylation | GKGAMVASFSPAAGQ CCCCEEEEECCCCCC | 18.17 | 25850435 | |
422 | Phosphorylation | GAMVASFSPAAGQLA CCEEEEECCCCCCCC | 15.90 | 25159151 | |
430 | Phosphorylation | PAAGQLATPESFIEP CCCCCCCCCHHHCCC | 35.86 | 25159151 | |
433 | Phosphorylation | GQLATPESFIEPPSK CCCCCCHHHCCCCCH | 32.50 | 22199227 | |
439 | Phosphorylation | ESFIEPPSKTAAARV HHHCCCCCHHHHHHH | 54.04 | 26074081 | |
448 | Ubiquitination | TAAARVAASASLSNM HHHHHHHHHHHHHHH | 11.63 | 29967540 | |
449 | Phosphorylation | AAARVAASASLSNMV HHHHHHHHHHHHHHC | 14.51 | 20068231 | |
451 | Phosphorylation | ARVAASASLSNMVLA HHHHHHHHHHHHCHH | 29.81 | 32142685 | |
453 | Phosphorylation | VAASASLSNMVLAPL HHHHHHHHHHCHHHH | 22.00 | 33259812 | |
456 | Phosphorylation | SASLSNMVLAPLQSM HHHHHHHCHHHHHHH | 4.89 | 32142685 | |
462 | Phosphorylation | MVLAPLQSMQQNQDP HCHHHHHHHHHCCCC | 26.66 | 20068231 | |
465 | Ubiquitination | APLQSMQQNQDPEVF HHHHHHHHCCCCCHH | 40.69 | 29967540 | |
482 | Ubiquitination | PKVLSSAIQVAGAPL HHHHHHHHHHCCCCC | 3.51 | 29967540 | |
485 | Phosphorylation | LSSAIQVAGAPLVTA HHHHHHHCCCCCEEE | 7.64 | 32142685 | |
487 | Phosphorylation | SAIQVAGAPLVTATT HHHHHCCCCCEEECC | 5.63 | 32142685 | |
490 | Phosphorylation | QVAGAPLVTATTTAV HHCCCCCEEECCHHH | 3.13 | 32142685 | |
491 | O-linked_Glycosylation | VAGAPLVTATTTAVS HCCCCCEEECCHHHH | 26.43 | 23301498 | |
493 | O-linked_Glycosylation | GAPLVTATTTAVSSV CCCCEEECCHHHHHH | 18.47 | 23301498 | |
494 | O-linked_Glycosylation | APLVTATTTAVSSVL CCCEEECCHHHHHHH | 15.42 | 23301498 | |
495 | O-linked_Glycosylation | PLVTATTTAVSSVLL CCEEECCHHHHHHHH | 22.25 | 23301498 | |
498 | O-linked_Glycosylation | TATTTAVSSVLLAPS EECCHHHHHHHHCHH | 16.56 | 23301498 | |
499 | O-linked_Glycosylation | ATTTAVSSVLLAPSV ECCHHHHHHHHCHHH | 15.36 | 23301498 | |
499 | Ubiquitination | ATTTAVSSVLLAPSV ECCHHHHHHHHCHHH | 15.36 | 29967540 | |
515 | O-linked_Glycosylation | QQTVTRSSDLERKAS CCCCCCCHHHHHHCC | 42.81 | 23301498 | |
520 | Ubiquitination | RSSDLERKASSPSPL CCHHHHHHCCCCCCC | 43.15 | 29967540 | |
522 | Phosphorylation | SDLERKASSPSPLTI HHHHHHCCCCCCCCC | 45.90 | 29255136 | |
523 | Phosphorylation | DLERKASSPSPLTIG HHHHHCCCCCCCCCC | 33.97 | 29255136 | |
525 | Phosphorylation | ERKASSPSPLTIGTP HHHCCCCCCCCCCCC | 34.19 | 19664994 | |
528 | Phosphorylation | ASSPSPLTIGTPESQ CCCCCCCCCCCCHHH | 22.27 | 29255136 | |
531 | Phosphorylation | PSPLTIGTPESQRKP CCCCCCCCCHHHCCC | 21.74 | 19664994 | |
534 | Phosphorylation | LTIGTPESQRKPSII CCCCCCHHHCCCEEE | 36.17 | 30266825 | |
537 | Ubiquitination | GTPESQRKPSIILSK CCCHHHCCCEEEEEH | 35.16 | 29967540 | |
539 | Phosphorylation | PESQRKPSIILSKSQ CHHHCCCEEEEEHHH | 25.87 | 23882029 | |
543 | Phosphorylation | RKPSIILSKSQLQDT CCCEEEEEHHHHHHH | 21.61 | 30576142 | |
545 | Phosphorylation | PSIILSKSQLQDTLI CEEEEEHHHHHHHHH | 32.52 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
315 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DCP1A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DCP1A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-315; SER-319;SER-353; SER-522; SER-523; SER-525 AND THR-531, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522; SER-523; SER-525AND THR-531, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; SER-315; SER-319;SER-334; THR-401; SER-522; SER-523; SER-525 AND THR-531, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319; SER-353AND THR-401, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-319; SER-334AND THR-531, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-525, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523 AND SER-525, ANDMASS SPECTROMETRY. |